Home > Resources > Application

InvivoCrown-Flyer

Date: Jun 04, 2025

InvivoCrown-Flyer

Related News

Enhancing Tumor Immunotherapy: InVivoPro Anti-Mouse PD-1 (CD279) Antibody, Clone RMP1-14 for Preclinical Research
Enhancing Tumor Immunotherapy: InVivoPro Anti-Mouse PD-1 (CD279) Antibody, Clone RMP1-14 for Preclinical Research

The InVivoPro Anti-Mouse PD-1 (CD279) in vivo antibody, Clone RMP1-14 has emerged as a pivotal tool in preclinical cancer immunotherapy research, enabling robust blockade of the PD-1/PD-L1 immune checkpoint pathway. This high-specificity monoclonal antibo

Unleashing Antitumor Immunity: InVivoPro Anti-Mouse PD-L1 (B7-H1, CD274) Antibody, Clone 10F.9G2 for Preclinical Research
Unleashing Antitumor Immunity: InVivoPro Anti-Mouse PD-L1 (B7-H1, CD274) Antibody, Clone 10F.9G2 for Preclinical Research

The InVivoPro Anti-Mouse PD-L1 (B7-H1, CD274) in vivo antibody, Clone 10F.9G2 is a cutting-edge tool for preclinical cancer immunotherapy research, designed to block the PD-1/PD-L1 immune checkpoint pathway with high specificity and efficacy. Developed by

InvivoCrown-Flyer
InvivoCrown-Flyer